How many insider declarations has AH Equity Partners Bio II, L.L.C. filed?

AH Equity Partners Bio II, L.L.C. has filed 3 public insider declarations with SEC (Form 4).

What is AH Equity Partners Bio II, L.L.C.'s role?

AH Equity Partners Bio II, L.L.C.'s reported role is not specified by the regulator across the filings.

Which companies does AH Equity Partners Bio II, L.L.C. report trades for?

AH Equity Partners Bio II, L.L.C. reports trades for 2 companies, including EQRx, Inc..

What is AH Equity Partners Bio II, L.L.C.'s declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 10.1M€.

← Executives ★ Sign in to follow

AE

AH Equity Partners Bio II, L.L.C.

·SEC (Form 4)

EQRx, Inc.Nautilus Biotechnology, Inc.

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

€10m

▼ Sales (2 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

2

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the complete record of transactions filed by AH Equity Partners Bio II, L.L.C.. Insider active across 2 companies, notably EQRx, Inc.. Cumulatively, 3 filings have been logged. Split: 0 buy · 2 sells. Total volume traded: €10.1m. History available since 2 June 2026. The latest transaction was disclosed on 2 June 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.

Companies and markets linked to AH Equity Partners Bio II, L.L.C.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

EQRx, Inc. (US)Nautilus Biotechnology, Inc. (US)

Declarations3 total

▼

AH Equity Partners Bio II, L.L.C.

10% OwnerExecutives2 Jun 2026Nautilus Biotechnology, Inc.

$11M28SEC ↗

4,615,974 shares@ US$2.3510.07% mcap92.3% of flowCommon StockSEC:0001231919-26-000599:0

▼

AH Equity Partners Bio II, L.L.C.

10% OwnerExecutives2 Jun 2026Nautilus Biotechnology, Inc.

$902,46115SEC ↗

384,026 shares@ US$2.350.84% mcap7.7% of flowCommon StockSEC:0001231919-26-000599:1

●

AH Equity Partners Bio II, L.L.C.

Executives9 Nov 2023EQRx, Inc.

0SEC ↗

12,264 sharesCommon StockSEC:0000899243-23-020289:0

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

AE

AH Equity Partners Bio II, L.L.C.

·SEC (Form 4)

EQRx, Inc.Nautilus Biotechnology, Inc.

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

€10m

▼ Sales (2 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

2

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the complete record of transactions filed by AH Equity Partners Bio II, L.L.C.. Insider active across 2 companies, notably EQRx, Inc.. Cumulatively, 3 filings have been logged. Split: 0 buy · 2 sells. Total volume traded: €10.1m. History available since 2 June 2026. The latest transaction was disclosed on 2 June 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.